Vycor Medical, Inc.
Moat Score — Vycor Medical, Inc.
Total Moat Score
6 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 2 / 5 | The ViewSite Brain Access System holds FDA 510(k) clearance, CE marking, and a Health Canada license -- a genuine regulatory moat for a company this small, in a niche narrow enough that the filing names no direct competitors. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 1 / 5 | Sharing overhead between the Vycor Medical and NovaVision divisions keeps costs low relative to the regulatory certifications maintained, but with just 7 employees and a going-concern warning, this is a survival necessity rather than a true competitive cost advantage. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 1 / 5 | As a niche surgical access device with no named direct competitor, Vycor likely retains some pricing latitude on VBAS, but its severe financial distress limits any real negotiating leverage with hospital and distributor customers. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | Neurosurgical access devices and vision-rehab software carry no network effect -- one surgeon's or patient's use does not make the product more valuable to another. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 1 / 5 | Surgeons who become familiar with the VBAS retraction technique in the operating room face some retraining friction to switch, but this is a modest, procedure-level stickiness rather than a structural lock-in. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 1 / 5 | The lack of a named direct competitor for VBAS suggests the niche may be too small to attract larger device makers, which protects Vycor's position somewhat, but the company's going-concern status shows this scale is not sufficient to be a reliably profitable, self-sustaining business. |